302 EAST PETTIGREW STREET, DURHAM, NC
News
First Amendment to Loan Agreement Extends Maturity Date to 2029
Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026
Approval of Amended 2019 Incentive Award Plan at Annual Meeting
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update
Receives U.S. FDA Clearance of Investigational New Drug Application for First-in-Class PBGENE-DMD for Treatment of Duchenne Muscular Dystrophy
Q1
FY 2025
Q3
Q2
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Free Writing Prospectus